KRMN shows strong revenue growth of 36.6% following its February 2025 IPO, but operating cash flow turned negative despite improved profitability.
The company appears to be in a growth phase with substantial increases in revenue, assets, and equity following its public offering. However, the swing from positive $26.6M to negative $22.1M operating cash flow despite higher net income suggests potential working capital challenges or timing issues that warrant monitoring.
KRMN delivered strong top-line growth with revenue increasing 36.6% to $471.5M and gross profit rising 43.8% to $190.0M, while net income grew 36.7% to $17.4M. The balance sheet strengthened significantly with cash nearly tripling to $34.0M and stockholders' equity doubling to $382.7M, likely reflecting IPO proceeds. However, the dramatic reversal in operating cash flow from positive $26.6M to negative $22.1M, combined with higher accounts receivable and capital expenditures, suggests the company is investing heavily for growth but may be experiencing collection or working capital management challenges.
Cash position surged 194.5% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow fell 183% — earnings quality concerns; investigate working capital changes and non-cash items.
Equity base grew 95.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 44.5% — improving short-term liquidity or inventory/receivables build.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Asset base grew 42.7% — expansion through organic growth, acquisitions, or capital deployment.
Receivables surged 42.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Net income grew 36.7% — bottom-line growth signals improving overall business health.
Strong top-line growth of 36.6% — accelerating demand or successful expansion into new markets.
Capital expenditure jumped 33.3% — major investment cycle underway; assess returns on deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →